This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Oudijk, M. A. Articles by Meijboom, E. J. Search for Related Content PubMed PubMed Citation Articles by Oudijk, M. A. Articles by Meijboom, E. J.

Treatment of fetal tachycardia with sotalol: transplacental pharmacokinetics and pharmacodynamics

Martijn A. Oudijk, MD, PhD^*,*, Jopje M. Ruskamp, MD, F. F. Tessa Ververs, PharmD, E. Barbara Ambachtsheer, MD, Philip Stoutenbeek, MD, PhD^*, Gerard H. A. Visser, MD, PhD^* and Erik J. Meijboom, MD, PhD, FACC

^* Department of Obstetrics, Utrecht, The Netherlands
Division of Pediatric Cardiology, Utrecht, The Netherlands
Division of Hospital Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands
Division of Pediatric Cardiology, Central Hospital University of Vaud, Lausanne, Switzerland

View larger version (15K): [in a new window]   Figure 1 Details on diagnosis, treatment modalities, and outcome of all cases. SVT = supraventricular tachycardia; AF = atrial flutter; SC = Caesarean section.

View larger version (22K): [in a new window]   Figure 2 Mean interquartile range and overall range of maternal blood levels of sotalol per daily dosage. Number of women with observations is shown within brackets. A linear relationship between blood level and increasing dosage is shown.

View larger version (21K): [in a new window]   Figure 3 Mean interquartile range and overall range of umbilical blood level of sotalol per daily maternal dosage. Number of observations is shown within brackets.